Original data (with adjusted standard errors for multi-arm studies):

              treat1       treat2      TE   seTE seTE.adj.f seTE.adj.r narms multiarm
2            placebo     zolpidem -0.3245 0.1286     0.1286     0.2227     2         
5            placebo     zolpidem -0.5771 0.1389     0.2242     0.2957     3        *
5           zaleplon     zolpidem -0.2193 0.1105     0.1223     0.2533     3        *
5            placebo     zaleplon -0.3578 0.1144     0.1280     0.2576     3        *
6        eszopiclone      placebo  0.4040 0.1026     0.1026     0.2088     2         
25           placebo     zaleplon -0.0474 0.1196     0.1373     0.2611     3        *
25           placebo     zolpidem -0.3795 0.1397     0.1970     0.2912     3        *
25          zaleplon     zolpidem -0.3321 0.1228     0.1429     0.2651     3        *
32           placebo     zaleplon  0.0346 0.1195     0.1369     0.2608     3        *
32          zaleplon     zolpidem -0.3578 0.1236     0.1441     0.2658     3        *
32           placebo     zolpidem -0.3232 0.1403     0.1980     0.2917     3        *
39           placebo     zolpidem -0.6596 0.1258     0.1258     0.2211     2         
43           placebo     zaleplon -0.1360 0.1054     0.1054     0.2102     2         
45           placebo   suvorexant -0.2618 0.0836     0.0836     0.2001     2         
46           placebo   suvorexant -0.3678 0.0877     0.0877     0.2019     2         
47           placebo     zolpidem -1.2938 0.4804     0.4804     0.5136     2         
48          zaleplon     zolpidem -0.1046 0.1337     0.1337     0.2257     2         
49          zaleplon     zolpidem -0.1040 0.2889     0.2889     0.3413     2         
58       eszopiclone      placebo  0.6757 0.0841     0.0841     0.2003     2         
59           placebo     zolpidem -0.5665 0.0672     0.0672     0.1939     2         
60           doxepin      placebo  0.4245 0.1584     0.1584     0.2412     2         
63           doxepin      placebo  0.1905 0.1258     0.1258     0.2211     2         
65         melatonin      placebo  0.3116 0.1544     0.1544     0.2386     2         
67  BZD-intermediate      placebo  1.7139 0.1166     0.1166     0.2160     2         
70         melatonin      placebo -0.5156 0.3214     0.3214     0.3693     2         
77       eszopiclone      placebo  0.3887 0.1265     0.1265     0.2215     2         
81           placebo     zolpidem -1.1706 0.6248     0.6248     0.6508     2         
85           placebo     zolpidem  0.6579 0.3251     0.3251     0.3725     2         
99      daridorexant     zolpidem -0.1781 0.1581     0.1824     0.2879     3        *
99           placebo     zolpidem -0.2493 0.1829     0.2597     0.3335     3        *
99      daridorexant      placebo  0.0712 0.1579     0.1821     0.2876     3        *
102          placebo     zolpidem -0.6990 0.1965     0.1965     0.2677     2         
106      eszopiclone    zopiclone  0.0835 0.1419     0.1419     0.2306     2         
111 BZD-intermediate      placebo  1.0047 0.3468     0.4375     0.4905     3        *
111 BZD-intermediate trimipramine  0.2783 0.3300     0.3954     0.4536     3        *
111          placebo trimipramine -0.7264 0.3361     0.4091     0.4659     3        *
112          placebo     zolpidem -0.5690 0.2140     0.2140     0.2808     2         
120      eszopiclone      placebo  0.3387 0.1392     0.1392     0.2290     2         
123      eszopiclone      placebo  0.4555 0.2344     0.2344     0.2967     2         
127          placebo    ramelteon -0.1953 0.0651     0.0651     0.1931     2         
128 BZD-intermediate     zolpidem -0.0118 0.1432     0.1432     0.2315     2         
129        melatonin      placebo  0.1351 0.1096     0.1096     0.2123     2         
130        melatonin      placebo  0.2146 0.0746     0.0746     0.1966     2         
132          placebo    trazodone -0.2236 0.1467     0.1790     0.2857     3        *
132        trazodone     zolpidem  0.0344 0.1487     0.1840     0.2888     3        *
132          placebo     zolpidem -0.1892 0.1462     0.1778     0.2850     3        *
135          placebo     zolpidem -0.1402 0.1653     0.1653     0.2457     2         
136      eszopiclone      placebo  0.8214 0.0762     0.0762     0.1971     2         
137          placebo     zolpidem -0.4212 0.1439     0.1439     0.2319     2         
144      eszopiclone      placebo  0.3319 0.1260     0.1260     0.2212     2         
145          placebo    ramelteon -0.1428 0.1219     0.1219     0.2189     2         
146      eszopiclone    zopiclone  0.0000 0.1333     0.1333     0.2255     2         
153      lemborexant     zolpidem -0.0275 0.0778     0.0873     0.2382     3        *
153          placebo     zolpidem -0.4217 0.0961     0.1415     0.2579     3        *
153      lemborexant      placebo  0.3942 0.0842     0.0977     0.2441     3        *
155      lemborexant      placebo  0.2842 0.0716     0.0716     0.1954     2         
158          placebo  seltorexant -0.3277 0.1384     0.1548     0.2709     3        *
158          placebo     zolpidem -0.2303 0.1699     0.2660     0.3264     3        *
158      seltorexant     zolpidem  0.0974 0.1402     0.1574     0.2730     3        *
159     daridorexant      placebo  0.2747 0.0699     0.0699     0.1948     2         
160     daridorexant      placebo  0.2498 0.0808     0.0808     0.1990     2         
162          placebo   quetiapine -0.0506 0.5564     0.5564     0.5854     2         

Number of treatment arms (by study):
    narms
2       2
5       3
6       2
25      3
32      3
39      2
43      2
45      2
46      2
47      2
48      2
49      2
58      2
59      2
60      2
63      2
65      2
67      2
70      2
77      2
81      2
85      2
99      3
102     2
106     2
111     3
112     2
120     2
123     2
127     2
128     2
129     2
130     2
132     3
135     2
136     2
137     2
144     2
145     2
146     2
153     3
155     2
158     3
159     2
160     2
162     2

Results (fixed effects model):

              treat1       treat2     SMD             95%-CI     Q leverage
2            placebo     zolpidem -0.4639 [-0.5264; -0.4014]  1.17     0.06
5            placebo     zolpidem -0.4639 [-0.5264; -0.4014]  0.25        .
5           zaleplon     zolpidem -0.2860 [-0.3805; -0.1915]  0.30        .
5            placebo     zaleplon -0.1779 [-0.2714; -0.0845]  1.97        .
6        eszopiclone      placebo  0.5735 [ 0.4938;  0.6533]  2.73     0.16
25           placebo     zaleplon -0.1779 [-0.2714; -0.0845]  0.90        .
25           placebo     zolpidem -0.4639 [-0.5264; -0.4014]  0.18        .
25          zaleplon     zolpidem -0.2860 [-0.3805; -0.1915]  0.10        .
32           placebo     zaleplon -0.1779 [-0.2714; -0.0845]  2.41        .
32          zaleplon     zolpidem -0.2860 [-0.3805; -0.1915]  0.25        .
32           placebo     zolpidem -0.4639 [-0.5264; -0.4014]  0.51        .
39           placebo     zolpidem -0.4639 [-0.5264; -0.4014]  2.42     0.06
43           placebo     zaleplon -0.1779 [-0.2714; -0.0845]  0.16     0.20
45           placebo   suvorexant -0.3122 [-0.4308; -0.1936]  0.36     0.52
46           placebo   suvorexant -0.3122 [-0.4308; -0.1936]  0.40     0.48
47           placebo     zolpidem -0.4639 [-0.5264; -0.4014]  2.98     0.00
48          zaleplon     zolpidem -0.2860 [-0.3805; -0.1915]  1.84     0.13
49          zaleplon     zolpidem -0.2860 [-0.3805; -0.1915]  0.40     0.03
58       eszopiclone      placebo  0.5735 [ 0.4938;  0.6533]  1.48     0.23
59           placebo     zolpidem -0.4639 [-0.5264; -0.4014]  2.33     0.22
60           doxepin      placebo  0.2810 [ 0.0879;  0.4741]  0.82     0.39
63           doxepin      placebo  0.2810 [ 0.0879;  0.4741]  0.52     0.61
65         melatonin      placebo  0.1840 [ 0.0735;  0.2945]  0.68     0.13
67  BZD-intermediate      placebo  1.1977 [ 1.0246;  1.3708] 19.59     0.57
70         melatonin      placebo  0.1840 [ 0.0735;  0.2945]  4.74     0.03
77       eszopiclone      placebo  0.5735 [ 0.4938;  0.6533]  2.13     0.10
81           placebo     zolpidem -0.4639 [-0.5264; -0.4014]  1.28     0.00
85           placebo     zolpidem -0.4639 [-0.5264; -0.4014] 11.91     0.01
99      daridorexant     zolpidem -0.2122 [-0.3242; -0.1001]  0.04        .
99           placebo     zolpidem -0.4639 [-0.5264; -0.4014]  0.68        .
99      daridorexant      placebo  0.2517 [ 0.1558;  0.3477]  0.98        .
102          placebo     zolpidem -0.4639 [-0.5264; -0.4014]  1.43     0.03
106      eszopiclone    zopiclone  0.0392 [-0.1513;  0.2296]  0.10     0.47
111 BZD-intermediate      placebo  1.1977 [ 1.0246;  1.3708]  0.19        .
111 BZD-intermediate trimipramine  0.3715 [-0.1919;  0.9350]  0.06        .
111          placebo trimipramine -0.8261 [-1.3905; -0.2618]  0.06        .
112          placebo     zolpidem -0.4639 [-0.5264; -0.4014]  0.24     0.02
120      eszopiclone      placebo  0.5735 [ 0.4938;  0.6533]  2.85     0.09
123      eszopiclone      placebo  0.5735 [ 0.4938;  0.6533]  0.25     0.03
127          placebo    ramelteon -0.1837 [-0.2963; -0.0710]  0.03     0.78
128 BZD-intermediate     zolpidem  0.7338 [ 0.5578;  0.9097] 27.10     0.39
129        melatonin      placebo  0.1840 [ 0.0735;  0.2945]  0.20     0.26
130        melatonin      placebo  0.1840 [ 0.0735;  0.2945]  0.17     0.57
132          placebo    trazodone -0.3572 [-0.6105; -0.1039]  0.56        .
132        trazodone     zolpidem -0.1067 [-0.3603;  0.1468]  0.59        .
132          placebo     zolpidem -0.4639 [-0.5264; -0.4014]  2.39        .
135          placebo     zolpidem -0.4639 [-0.5264; -0.4014]  3.84     0.04
136      eszopiclone      placebo  0.5735 [ 0.4938;  0.6533] 10.58     0.29
137          placebo     zolpidem -0.4639 [-0.5264; -0.4014]  0.09     0.05
144      eszopiclone      placebo  0.5735 [ 0.4938;  0.6533]  3.68     0.10
145          placebo    ramelteon -0.1837 [-0.2963; -0.0710]  0.11     0.22
146      eszopiclone    zopiclone  0.0392 [-0.1513;  0.2296]  0.09     0.53
153      lemborexant     zolpidem -0.1066 [-0.2106; -0.0027]  0.82        .
153          placebo     zolpidem -0.4639 [-0.5264; -0.4014]  0.09        .
153      lemborexant      placebo  0.3573 [ 0.2610;  0.4536]  0.14        .
155      lemborexant      placebo  0.3573 [ 0.2610;  0.4536]  1.04     0.47
158          placebo  seltorexant -0.4426 [-0.6611; -0.2240]  0.55        .
158          placebo     zolpidem -0.4639 [-0.5264; -0.4014]  0.77        .
158      seltorexant     zolpidem -0.0214 [-0.2400;  0.1973]  0.57        .
159     daridorexant      placebo  0.2517 [ 0.1558;  0.3477]  0.11     0.49
160     daridorexant      placebo  0.2517 [ 0.1558;  0.3477]  0.00     0.37
162          placebo   quetiapine -0.0506 [-1.1412;  1.0400]  0.00     1.00

Results (random effects model):

              treat1       treat2     SMD             95%-CI
2            placebo     zolpidem -0.4403 [-0.5526; -0.3280]
5            placebo     zolpidem -0.4403 [-0.5526; -0.3280]
5           zaleplon     zolpidem -0.2659 [-0.4406; -0.0912]
5            placebo     zaleplon -0.1744 [-0.3504;  0.0016]
6        eszopiclone      placebo  0.5080 [ 0.3451;  0.6709]
25           placebo     zaleplon -0.1744 [-0.3504;  0.0016]
25           placebo     zolpidem -0.4403 [-0.5526; -0.3280]
25          zaleplon     zolpidem -0.2659 [-0.4406; -0.0912]
32           placebo     zaleplon -0.1744 [-0.3504;  0.0016]
32          zaleplon     zolpidem -0.2659 [-0.4406; -0.0912]
32           placebo     zolpidem -0.4403 [-0.5526; -0.3280]
39           placebo     zolpidem -0.4403 [-0.5526; -0.3280]
43           placebo     zaleplon -0.1744 [-0.3504;  0.0016]
45           placebo   suvorexant -0.3143 [-0.5929; -0.0358]
46           placebo   suvorexant -0.3143 [-0.5929; -0.0358]
47           placebo     zolpidem -0.4403 [-0.5526; -0.3280]
48          zaleplon     zolpidem -0.2659 [-0.4406; -0.0912]
49          zaleplon     zolpidem -0.2659 [-0.4406; -0.0912]
58       eszopiclone      placebo  0.5080 [ 0.3451;  0.6709]
59           placebo     zolpidem -0.4403 [-0.5526; -0.3280]
60           doxepin      placebo  0.2974 [-0.0221;  0.6168]
63           doxepin      placebo  0.2974 [-0.0221;  0.6168]
65         melatonin      placebo  0.1404 [-0.0890;  0.3699]
67  BZD-intermediate      placebo  1.1000 [ 0.8094;  1.3906]
70         melatonin      placebo  0.1404 [-0.0890;  0.3699]
77       eszopiclone      placebo  0.5080 [ 0.3451;  0.6709]
81           placebo     zolpidem -0.4403 [-0.5526; -0.3280]
85           placebo     zolpidem -0.4403 [-0.5526; -0.3280]
99      daridorexant     zolpidem -0.2083 [-0.4525;  0.0358]
99           placebo     zolpidem -0.4403 [-0.5526; -0.3280]
99      daridorexant      placebo  0.2320 [ 0.0061;  0.4579]
102          placebo     zolpidem -0.4403 [-0.5526; -0.3280]
106      eszopiclone    zopiclone  0.0408 [-0.2752;  0.3568]
111 BZD-intermediate      placebo  1.1000 [ 0.8094;  1.3906]
111 BZD-intermediate trimipramine  0.3247 [-0.3278;  0.9772]
111          placebo trimipramine -0.7753 [-1.4296; -0.1211]
112          placebo     zolpidem -0.4403 [-0.5526; -0.3280]
120      eszopiclone      placebo  0.5080 [ 0.3451;  0.6709]
123      eszopiclone      placebo  0.5080 [ 0.3451;  0.6709]
127          placebo    ramelteon -0.1723 [-0.4562;  0.1115]
128 BZD-intermediate     zolpidem  0.6597 [ 0.3648;  0.9546]
129        melatonin      placebo  0.1404 [-0.0890;  0.3699]
130        melatonin      placebo  0.1404 [-0.0890;  0.3699]
132          placebo    trazodone -0.3478 [-0.7498;  0.0542]
132        trazodone     zolpidem -0.0925 [-0.4946;  0.3097]
132          placebo     zolpidem -0.4403 [-0.5526; -0.3280]
135          placebo     zolpidem -0.4403 [-0.5526; -0.3280]
136      eszopiclone      placebo  0.5080 [ 0.3451;  0.6709]
137          placebo     zolpidem -0.4403 [-0.5526; -0.3280]
144      eszopiclone      placebo  0.5080 [ 0.3451;  0.6709]
145          placebo    ramelteon -0.1723 [-0.4562;  0.1115]
146      eszopiclone    zopiclone  0.0408 [-0.2752;  0.3568]
153      lemborexant     zolpidem -0.0882 [-0.3523;  0.1759]
153          placebo     zolpidem -0.4403 [-0.5526; -0.3280]
153      lemborexant      placebo  0.3521 [ 0.0982;  0.6060]
155      lemborexant      placebo  0.3521 [ 0.0982;  0.6060]
158          placebo  seltorexant -0.4319 [-0.8129; -0.0508]
158          placebo     zolpidem -0.4403 [-0.5526; -0.3280]
158      seltorexant     zolpidem -0.0084 [-0.3896;  0.3727]
159     daridorexant      placebo  0.2320 [ 0.0061;  0.4579]
160     daridorexant      placebo  0.2320 [ 0.0061;  0.4579]
162          placebo   quetiapine -0.0506 [-1.1980;  1.0967]

Number of studies: k = 46
Number of pairwise comparisons: m = 62
Number of observations: o = 16428
Number of treatments: n = 16
Number of designs: d = 20

Fixed effects model

Treatment estimate (sm = 'SMD', comparison: other treatments vs 'placebo'):
                    SMD            95%-CI     z  p-value
BZD-intermediate 1.1977 [ 1.0246; 1.3708] 13.56 < 0.0001
daridorexant     0.2517 [ 0.1558; 0.3477]  5.14 < 0.0001
doxepin          0.2810 [ 0.0879; 0.4741]  2.85   0.0043
eszopiclone      0.5735 [ 0.4938; 0.6533] 14.10 < 0.0001
lemborexant      0.3573 [ 0.2610; 0.4536]  7.27 < 0.0001
melatonin        0.1840 [ 0.0735; 0.2945]  3.26   0.0011
placebo               .                 .     .        .
quetiapine       0.0506 [-1.0400; 1.1412]  0.09   0.9275
ramelteon        0.1837 [ 0.0710; 0.2963]  3.20   0.0014
seltorexant      0.4426 [ 0.2240; 0.6611]  3.97 < 0.0001
suvorexant       0.3122 [ 0.1936; 0.4308]  5.16 < 0.0001
trazodone        0.3572 [ 0.1039; 0.6105]  2.76   0.0057
trimipramine     0.8261 [ 0.2618; 1.3905]  2.87   0.0041
zaleplon         0.1779 [ 0.0845; 0.2714]  3.73   0.0002
zolpidem         0.4639 [ 0.4014; 0.5264] 14.54 < 0.0001
zopiclone        0.5344 [ 0.3279; 0.7408]  5.07 < 0.0001

Random effects model

Treatment estimate (sm = 'SMD', comparison: other treatments vs 'placebo'):
                    SMD            95%-CI    z  p-value            95%-PI
BZD-intermediate 1.1000 [ 0.8094; 1.3906] 7.42 < 0.0001 [ 0.6251; 1.5749]
daridorexant     0.2320 [ 0.0061; 0.4579] 2.01   0.0441 [-0.2038; 0.6678]
doxepin          0.2974 [-0.0221; 0.6168] 1.82   0.0681 [-0.1969; 0.7917]
eszopiclone      0.5080 [ 0.3451; 0.6709] 6.11 < 0.0001 [ 0.1033; 0.9127]
lemborexant      0.3521 [ 0.0982; 0.6060] 2.72   0.0066 [-0.0999; 0.8040]
melatonin        0.1404 [-0.0890; 0.3699] 1.20   0.2303 [-0.2974; 0.5782]
placebo               .                 .    .        .                 .
quetiapine       0.0506 [-1.0967; 1.1980] 0.09   0.9311 [-1.1903; 1.2915]
ramelteon        0.1723 [-0.1115; 0.4562] 1.19   0.2341 [-0.2983; 0.6429]
seltorexant      0.4319 [ 0.0508; 0.8129] 2.22   0.0263 [-0.1070; 0.9708]
suvorexant       0.3143 [ 0.0358; 0.5929] 2.21   0.0270 [-0.1529; 0.7815]
trazodone        0.3478 [-0.0542; 0.7498] 1.70   0.0899 [-0.2071; 0.9027]
trimipramine     0.7753 [ 0.1211; 1.4296] 2.32   0.0202 [ 0.0058; 1.5448]
zaleplon         0.1744 [-0.0016; 0.3504] 1.94   0.0521 [-0.2362; 0.5849]
zolpidem         0.4403 [ 0.3280; 0.5526] 7.68 < 0.0001 [ 0.0543; 0.8262]
zopiclone        0.4672 [ 0.1117; 0.8227] 2.58   0.0100 [-0.0527; 0.9871]

Quantifying heterogeneity / inconsistency:
tau^2 = 0.0331; tau = 0.1818; I^2 = 68.9% [56.9%; 77.5%]

Tests of heterogeneity (within designs) and inconsistency (between designs):
                     Q d.f.  p-value
Total           125.22   39 < 0.0001
Within designs   65.55   28 < 0.0001
Between designs  59.67   11 < 0.0001
[1] "A total of 16 treatments are included in the network."
[1] "A total of 46 studies are included in this analysis."
[1] "Estimated heterogeneity tau-squared0.03"
[1] "Global test for inconsistency, p-value 0 (Q=60, d.o.f. 11)"
[1] "File created on 2022-06-08"
